Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

NDAQ:LEXX - Post Discussion

Lexaria Bioscience Corp > $LEXX 22$ in 2022
View:
Post by SkyLight8 on Dec 10, 2021 9:08pm

$LEXX 22$ in 2022

See our video with $LEXX CEO Chris Bunka where we talk about DehydraTECH. linkedin.com/posts/john-van See our initiation:s27.q4cdn.com/906368049/file #nicotine #hypertension #stockmarket #drugdelivery #biotech #stocks #cigarette
linkedin.com
John Vandermosten on LinkedIn: #ad
The first of three in-depth interviews John Vandermosten conducted with Chris Bunka of Lexaria ($LEXX) about the exciting developments in the compan
Comment by SkyLight8 on Dec 10, 2021 9:13pm
Post | Feed | LinkedIn
Comment by WakeUPP on Dec 14, 2021 10:26am
hahaaha SKylight still BELIEVES promtoion PAID FOR by LEXXX!!!!!!!! zaxks +SPONSORD, PAID FOR by LEXX to PROMOTE and' it WORKS as sklight (and otehre here) BELIEVE what is a COMMERICIAL everyone else WAKE THE F UP!!!!!!!!!
Lexaria Bioscience Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities